Key stats
About Amundi MSCI EMU High Dividend UCITS ETF FCP Parts -Acc-
Home page
Inception date
Feb 26, 2009
Structure
French FCP
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
Amundi Luxembourg SA
ISIN
FR0010717090
This fund closed on January 10, 2019.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Finance
Consumer Durables
Stocks100.00%
Finance31.95%
Consumer Durables11.99%
Utilities9.63%
Energy Minerals8.72%
Communications7.03%
Industrial Services5.60%
Retail Trade5.17%
Transportation4.91%
Health Technology4.28%
Producer Manufacturing4.03%
Consumer Non-Durables2.65%
Process Industries1.79%
Commercial Services1.78%
Consumer Services0.46%
Bonds, Cash & Other0.00%
Stock breakdown by region
Europe100.00%
North America0.00%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CD8 invests in stocks. The fund's major sectors are Finance, with 31.95% stocks, and Consumer Durables, with 11.99% of the basket. The assets are mostly located in the Europe region.
CD8 top holdings are Allianz SE and TotalEnergies SE, occupying 5.02% and 4.95% of the portfolio correspondingly.
CD8 assets under management is 236.47 M EUR. It's fallen 3.56% over the last month.
CD8 fund flows account for −1.81 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, CD8 doesn't pay dividends to its holders.
CD8 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Feb 26, 2009, and its management style is Passive.
CD8 expense ratio is 0.30% meaning you'd have to pay 0.30% of your investment to help manage the fund.
CD8 follows the MSCI EMU High Dividend Yield Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CD8 invests in stocks.
CD8 price has fallen by −5.19% over the last month, and its yearly performance shows a 8.43% increase. See more dynamics on CD8 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −5.32% over the last month, have fallen by −5.32% over the last month, showed a 1.34% increase in three-month performance and has increased by 7.95% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −5.32% over the last month, have fallen by −5.32% over the last month, showed a 1.34% increase in three-month performance and has increased by 7.95% in a year.
CD8 trades at a premium (0.14%) meaning the ETF is trading at a higher price than the calculated NAV.